WPA
IONS icon

Wealth Preservation Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Wealth Preservation Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3K Hold
150
– – 0.01% 398
2025
Q4 		$11.9K Hold
150
– – 0.01% 288
2025
Q3 		$9.81K Hold
150
– – 0.01% 297
2025
Q2 		$5.93K Hold
150
– – ﹤0.01% 342
2025
Q1 		$4.53K Buy
+150
New +$4.91K ﹤0.01% 389

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealth Preservation Advisors's IONS Position: Q1 2026 in Review

Wealth Preservation Advisors held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 150 shares worth $11.3K. The position accounts for 0.01% of the portfolio, ranked #398.

Wealth Preservation Advisors first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $11.9K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Wealth Preservation Advisors held 150 shares of Ionis Pharmaceuticals worth $11.3K as of Q1 2026.
  • Wealth Preservation Advisors left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up 0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #398 holding.
  • Wealth Preservation Advisors first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Wealth Preservation Advisors's Ionis Pharmaceuticals position peaked at $11.9K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.